Farmakopöa töökava asjus

Signe Leito Saatja: [email protected] Saatmisaeg: teisipäev, 15. oktoober 2024 16:44 Adressaat: Signe Leito Teema: Survey on Deletion of the revision of Methylprednisolone hydrogen succinate 1131 from the WP, Group 10B: EDQM-2024-04187-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2024-04187-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed deletion of the revision of Methylprednisolone hydrogen succinate (1131) from the work programme (Group10B). In order to have access to the survey, please copy and paste this link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=526488&lang=en Deadline for replies: 5 November 2024 Thank you. With kind regards On behalf of Sylvina Iossiphova ___ Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe 1 Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2024-04187-mail 2